RankAlpha logo
Back to Rankings

ACXP

AcurxF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
ACXP vs peer average
30/100
ACXP vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

XBIO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.74M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerXBIOXenetic Biosciences
ACXP
Acurx
XBIO
Xenetic Biosciences
Grade
F
C
Momentum
31
63
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs XBIO

ACXP / XBIO
Grade Position
Below peers
ACXP vs. peer average (F vs. D)
30/100
Momentum
31
XBIO
Value
41
ACXP
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ACXP
1
XBIO
Xenetic Biosciences Inc Common
C
60/100
-2
2
GNPX
Genprex Inc Common
D
40/100
-1
3
ASBP
Aspire Biopharma Holdings Inc Common
F
20/100
Even
4
BIAF
bioAffinity Technologies Inc Common
A
100/100
-4
5
APM
Aptorum Group Ltd Class A Common
F
20/100
Even
XBIO is the first peer returned for this comparison set.